Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.

Also called NCT07658807

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07658807
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07658807. Randomized; no masking; primary purpose prevention. Start 2026-06 (anticipated); primary completion 2028-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease
Condition
Peripheral Arterial Disease
Condition
Diabetic Angiopathies
Condition
Arterial Occlusive Diseases
Intervention (Drug)
Hua Yu Wan Capsule
Intervention (Drug)
Aspirin
Lead sponsor
Xuanwu Hospital, Beijing (class: other)
Collaborator
Affiliated Hospital of Shandong University of Traditional Chinese Medicine (class: other)
Collaborator
Dongzhimen Hospital, Beijing (class: other)
Collaborator
Peking University Third Hospital (class: other)

Record details

Record id
cardio:ct-nct07658807
Content hash
8cb6e324dad0c0ff227fa5360f69e1dc7b3f1117ebd34551de16113f09d5b966